Index S&P 500
P/E 19.86
EPS (ttm) 26.46
Insider Own 0.50%
Shs Outstand 233.07M
Perf Week -2.61%
Market Cap 122.16B
Forward P/E 12.62
EPS next Y 41.63
Insider Trans -4.29%
Shs Float 231.26M
Perf Month 3.88%
Income 6.24B
PEG 1.64
EPS next Q 10.03
Inst Own 91.60%
Short Float 0.84%
Perf Quarter 6.09%
Sales 171.75B
P/S 0.71
EPS this Y 12.46%
Inst Trans 0.08%
Short Ratio 2.00
Perf Half Y 16.78%
Book/sh 174.62
P/B 3.01
EPS next Y 11.71%
ROA 5.65%
Short Interest 1.94M
Perf Year 12.71%
Cash/sh -
P/C -
EPS next 5Y 12.10%
ROE 16.02%
52W Range 412.00 - 542.07
Perf YTD 11.46%
Dividend Est. 6.24 (1.19%)
P/FCF 53.21
EPS past 5Y 12.18%
ROI 9.98%
52W High -3.04%
Beta 0.84
Dividend TTM 6.07 (1.15%)
Quick Ratio -
Sales past 5Y 13.24%
Gross Margin -
52W Low 27.58%
ATR (14) 9.01
Dividend Ex-Date Jun 10, 2024
Current Ratio 1.37
EPS Y/Y TTM 2.51%
Oper. Margin 5.29%
RSI (14) 54.86
Volatility 1.46% 1.72%
Employees 104900
Debt/Eq 0.65
Sales Y/Y TTM 6.89%
Profit Margin 3.64%
Recom 1.50
Target Price 606.54
Option/Short Yes / Yes
LT Debt/Eq 0.54
EPS Q/Q 15.57%
Payout 23.47%
Rel Volume 1.28
Prev Close 524.84
Sales Surprise -0.52%
EPS Surprise 1.15%
Sales Q/Q 0.96%
Earnings Apr 18 BMO
Avg Volume 969.56K
Price 525.61
SMA20 1.34%
SMA50 2.49%
SMA200 9.95%
Trades
Volume 1,245,167
Change 0.15%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
Barclays
Overweight
$584
Jul-12-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated
Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade
BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$490 → $580
May-01-24 09:30AM
Apr-29-24 05:22PM
Apr-26-24 09:50AM
02:25AM
Apr-25-24 05:16PM
12:00PM
Loading…
12:00PM
Apr-24-24 09:45AM
Apr-23-24 09:40AM
Apr-22-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:32AM
03:02AM
01:01AM
Apr-18-24 11:49PM
(Thomson Reuters StreetEvents)
04:27PM
03:53PM
12:15PM
Loading…
12:15PM
11:58AM
11:18AM
10:53AM
10:45AM
(The Wall Street Journal)
09:41AM
09:30AM
08:15AM
07:10AM
06:17AM
06:09AM
(Associated Press Finance)
06:03AM
06:00AM
Apr-17-24 10:33AM
Apr-16-24 06:25PM
(The Wall Street Journal)
12:13PM
Loading…
12:13PM
Apr-15-24 04:17PM
11:28AM
09:19AM
07:00AM
Apr-11-24 10:00AM
Apr-09-24 02:13PM
Apr-06-24 07:00PM
Apr-03-24 04:51PM
12:10PM
Apr-02-24 05:23PM
(The Wall Street Journal)
04:41PM
04:01PM
(Investor's Business Daily)
10:39AM
07:20AM
07:02AM
(The Wall Street Journal)
Apr-01-24 11:17AM
Mar-31-24 11:03PM
Mar-30-24 06:50AM
Mar-28-24 04:05PM
03:22PM
(The Wall Street Journal)
Mar-26-24 05:25PM
Mar-25-24 04:44PM
08:39AM
Mar-22-24 06:15PM
Mar-21-24 08:02PM
02:08AM
Mar-20-24 09:21AM
Mar-19-24 03:35PM
11:53AM
Mar-18-24 06:23PM
(The Wall Street Journal)
04:50PM
04:48PM
04:19PM
Mar-17-24 12:55PM
Mar-15-24 12:57PM
Mar-14-24 06:15PM
Mar-13-24 09:30AM
Mar-12-24 11:16AM
Mar-11-24 07:13AM
06:15AM
06:15AM
Mar-06-24 05:02AM
Mar-05-24 06:15PM
04:02AM
Mar-02-24 10:42AM
Feb-28-24 09:10AM
Feb-24-24 12:09AM
Feb-23-24 11:30AM
Feb-22-24 06:15PM
04:30PM
04:05PM
Feb-19-24 09:40AM
Feb-17-24 01:29PM
Feb-15-24 04:05AM
Feb-14-24 08:13PM
01:42PM
Feb-13-24 04:45AM
Feb-05-24 04:03PM
11:30AM
Feb-02-24 09:40AM
Jan-28-24 01:14PM
Jan-25-24 10:51AM
10:06AM
(The Wall Street Journal)
Jan-24-24 11:51PM
(Thomson Reuters StreetEvents)
02:30PM
01:31PM
01:05PM
11:23AM
10:15AM
(The Wall Street Journal)
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM Dixon Robert L JR Director Jul 21 '23 Sale 476.71 310 147,780 9,638 Jul 21 05:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite